Clinical Trials | October 16, 2021
Metropolis Healthcare board approves acquisition of Hitech for Rs 636 crore
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
Equity raise to finance growth and investments in the biological space
Emkay Research expects Q2FY22 to be a normalised quarter for pharma companies that it tracks. A summary of the report
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
_256_384.jpg)
It works by collecting aerosols and identifies the presence of dangerous pathogens using sensitive, specific and rapid detection in near-real time without laboratory analysis
The survey revealed that improving customer experience (CX) and operational efficiencies are top priorities, which healthcare organizations aim to attain by deploying digital health solutions
The company plans to raise US $ 15 million
It has planned an investment of over Rs 80 crore in the next five years
Abiraterone by Dr Reddy's becomes the first anti-cancer drug from India to enter the Chinese market
Since its inception, the company has either acquired or taken a majority stake in five companies
Subscribe To Our Newsletter & Stay Updated
